(Q40980403)

25 September 2017

1 reference

title

bcl-2: role in epithelial differentiation and oncogenesis (English)

1 reference

25 September 2017

Lu QL

1

1 reference

25 September 2017

Abel P

series ordinal

2

1 reference

25 September 2017

Foster CS

series ordinal

3

1 reference

25 September 2017

Lalani EN

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

25 September 2017

1 reference

25 September 2017

volume

27

1 reference

25 September 2017

issue

2

1 reference

25 September 2017

page(s)

102-110

1 reference

Cellular oncogenes and retroviruses

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Tumor suppressor genes: a new era for molecular genetic studies of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Cooperative interaction between c-myc and bcl-2 proto-oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Apoptotic cell death induced by c-myc is inhibited by bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

A biochemical hallmark of apoptosis: internucleosomal degradation of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

The protooncogene bcl-2 inhibits apoptosis in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Bcl-2 and the regulation of programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Bcl-2 expression in adult and embryonic non-haematopoietic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Bcl-2 functions in an antioxidant pathway to prevent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Programmed cell death and Bcl-2 protection in very low oxygen.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Expression of BCL-2 in the developing human fetal and infant breast

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Ductal Heterogeneity of Cytokeratins, Gene Expression, and Cell Death in the Rat Ventral Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

bcl-2 expression in normal breast tissue during the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Programmed Cell Death in Terminally Differentiating Keratinocytes: Role of Endogenous Endonuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

bcl-2 protein in non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

BCL-2 induction is part of the strategy of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Oncogenic potential of bcl-2 demonstrated by gene transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

bcl-2 expression in epidermal keratinocytic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990362-7

7 January 2021

10.1016/S0046-8177(96)90362-7

Identifiers

DOI

1 reference

25 September 2017

1 reference